These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6137019)

  • 1. Pharmacokinetics of chlorazepate after intravenous and intramuscular administration.
    Bertler A; Lindgren S; Magnusson JO; Malmgren H
    Psychopharmacology (Berl); 1983; 80(3):236-9. PubMed ID: 6137019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular bioavailability of chlorazepate as compared to diazepam.
    Bertler A; Lindgren S; Magnusson JO; Malmgren H
    Eur J Clin Pharmacol; 1985; 28(2):229-30. PubMed ID: 2859206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmethyldiazepam kinetics after intravenous, intramuscular, and oral administration of clorazepate dipotassium.
    Ochs HR; Steinhaus E; Locniskar A; Knüchel M; Greenblatt DJ
    Klin Wochenschr; 1982 Apr; 60(8):411-5. PubMed ID: 6124654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of dipotassium chlorazepate in patients after repeated 50 mg oral doses.
    Bertler A; Lindgren S; Malmgren H
    Psychopharmacology (Berl); 1980; 71(2):165-7. PubMed ID: 6108593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of N-desmethyldiazepam in healthy volunteers after single daily doses of dipotassium chlorazepate.
    Post C; Lindgren S; Bertler A; Malmgren H
    Psychopharmacology (Berl); 1977 Jul; 53(2):105-9. PubMed ID: 19801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring clorazepate dipotassium as desmethyldiazepam in plasma by electron-capture gas--liquid chromatography.
    Haidukewych D; Rodin EA; Davenport R
    Clin Chem; 1980 Jan; 26(1):142-4. PubMed ID: 6101311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of N-desmethyldiazepam after a single oral dose of clorazepate: the effect of smoking.
    Norman TR; Fulton A; Burrows GD; Maguire KP
    Eur J Clin Pharmacol; 1981; 21(3):229-33. PubMed ID: 6119204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations and clinical effects after single oral doses of prazepam, clorazepate, and diazepam.
    Shader RI; Pary RJ; Harmatz JS; Allison S; Locniskar A; Greenblatt DJ
    J Clin Psychiatry; 1984 Oct; 45(10):411-3. PubMed ID: 6148339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmethyldiazepam pharmacokinetics: studies following intravenous and oral desmethyldiazepam, oral clorazepate, and intravenous diazepam.
    Greenblatt DJ; Divoll MK; Soong MH; Boxenbaum HG; Harmatz JS; Shader RI
    J Clin Pharmacol; 1988 Sep; 28(9):853-9. PubMed ID: 2906643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of dipotassium clorazepate in the plasma by gas chromatography (author's transl)].
    Rey E; Turquais JM; Olive G
    Ann Biol Clin (Paris); 1978; 36(4):355-8. PubMed ID: 32817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of propranolol coadministration or cigarette smoking on the kinetics of desmethyldiazepam following intravenous clorazepate.
    Ochs HR; Greenblatt DJ; Locniskar A; Weinbrenner J
    Klin Wochenschr; 1986 Dec; 64(23):1217-21. PubMed ID: 2879960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bioavailibility of dipotassium chlorazepate].
    Langenberg K; Staak M; Sticht G; Käferstein H
    Beitr Gerichtl Med; 1982; 40():329-34. PubMed ID: 6131664
    [No Abstract]   [Full Text] [Related]  

  • 13. Clorazepate, correlation between metabolism and anticonvulsant activity.
    Frey HH; Scherkl R
    Eur J Pharmacol; 1988 Dec; 158(3):213-6. PubMed ID: 2908106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and kinetics of chlorazepate administered to anxious patients in a single daily dose].
    Duguay R; Le Lorier J; Rochefort JG; Messier R; Viguié F; Adamkiewicz L
    Can J Psychiatry; 1985 Oct; 30(6):414-7. PubMed ID: 2866026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clorazepate in spasticity and rigidity: a quantitative study of reflexes and plasma concentrations.
    Lossius R; Dietrichson P; Lunde PK
    Acta Neurol Scand; 1985 Mar; 71(3):190-4. PubMed ID: 2859728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLC determination of plasma drug levels after oral administration of clorazepate potassium salts.
    Hoffman DJ; Chun AH
    J Pharm Sci; 1975 Oct; 64(10):1668-71. PubMed ID: 241829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state bioavailability of two clorazepate dipotassium dosage forms.
    Carrigan PJ; Chao GC; Barker WM; Hoffman DJ; Chun AH
    J Clin Pharmacol; 1977 Jan; 17(1):18-28. PubMed ID: 13089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetic studies after oral and parenteral application of dipotassium chlorazepate (author's transl)].
    Staak M; Moosmayer A; Besserer K; Speidel K; Kleinschmidt A
    Arzneimittelforschung; 1982; 32(3):272-5. PubMed ID: 6123331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of desmethyldiazepam in plasma by electron-capture GLC: application to pharmacokinetic studies of clorazepate.
    Greenblatt DJ
    J Pharm Sci; 1978 Mar; 67(3):427-9. PubMed ID: 25328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatography determination of dipotassium clorazepate and its major metabolite nordiazepam in plasma.
    Colin P; Sirois G; Lelorier J
    J Chromatogr; 1983 Apr; 273(2):367-77. PubMed ID: 6134746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.